Viatris and Ubie Launch Disease Awareness Project to Support Early Detection and Proper Consultation for Generalized Anxiety Disorder (GAD)
NQ Score
54/100
N1 Content Completeness
10
AI Summary (NQ-processed)
Viatris Japan and Ubie have launched a disease awareness project for GAD, utilizing AI to help potential patients recognize symptoms and seek appropriate medical care.
AI Analysis
Frequently Asked Questions
- Q: What is the prevalence of GAD in Japan?
- A: The lifetime prevalence is reported at 2.6%, while the prevalence of suspected GAD (GAD-7 score of 10+) is 7.6%.